SLC35A1 Knockout Cell Line - CD BioSciences

service-banner

SLC35A1 Knockout Cell Line

SLC35A1 Knockout Cell Line

SPL-03335

Size Price
1 Unit Online Inquiry
Description
2bp deletion
Target Information
Target Name SLC35A1
Gene Abbr. SLC35A1
Gene ID 10559
Full Name solute carrier family 35 member A1
Alias CDG2F, CMPST, CST, hCST
Species Human
Genomic Locus chr6:87477482
Transcript NM_006416
WT Expression Level 17.49 TPM (TPM = Transcripts per million; any value less than 3 is considered non-expressing)
Introduction The protein encoded by this gene is found in the membrane of the Golgi apparatus, where it transports nucleotide sugars into the Golgi. One such nucleotide sugar is CMP-sialic acid, which is imported into the Golgi by the encoded protein and subsequently glycosylated. Defects in this gene are a cause of congenital disorder of glycosylation type 2F (CDG2F). Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Dec 2009].
Product Details
Cell Line Model HAP1
Genotype HAP1 cell line, edited by CRISPR/Cas to contain a 2bp deletion in a coding exon of SLC35A1.
Description 2bp deletion
Parental Cell Line C631
Guide RNA Sequence TTCTGTGATACACACGGCTG
PCR Primer Forward: CACGTATTTTCCAGACAATGTCACT
Reverse: ACAAATACCCTCACCAGGTAGAAAA
Handling Specifications
Revival Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into 10 mL of pre-warmed media in a 10 cm dish.
Culture Medium IMDM + 10% FCS
Growth Properties Cells are adherent cells that are cultured at 37°C in a humidified atmosphere with 5% CO2. Cells should be passaged every 2-3 days, splitting approximately 1:10-1:20.
Freeze Medium IMDM + 20% FCS + 10% DMSO
Biosafety Level BSL-1
Disclaimer This product is classified under IATA regulations as a GMMO (genetically modified micro-organism) and will ship as UN3245. If applicable, ensure facility meets all requirements per local and country regulations.

For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.